Revolutionizing Atopic Dermatitis (RAD) 2019

Revolutionizing Atopic Dermatitis (RAD) 2019 is organized by Revolutionizing Atopic Dermatitis (RAD) and will be held from Apr 06 - 07, 2019 at Chicago Marriott O'Hare, Chicago, Illinois, United States of America.

This activity is intended for dermatologists and allergists engaged in the care of patients with atopic dermatitis. This CME Conference has been approved for a maximum of 6.5 AMA PRA Category 1 Credit(s)™.

Revolutionizing Atopic Dermatitis (RAD) is the first, and only, a global, multidisciplinary educational conference dedicated to educating dermatologists, allergists, primary care clinicians, nurse practitioners, physicians assistants, nurses, and other allied health professionals, and patients about atopic dermatitis

RAD will provide a state-of-the-art, evidence-based, and multidisciplinary forum for atopic dermatitis assessment and management, and features an outstanding line-up of speakers:
• Dr. Jonathan I Silverberg, Associate Professor of Dermatology, Medical Social Sciences and Preventive Medicine, at Northwestern University, Feinberg School of Medicine
• Dr. Jacob Thyssen, Professor, Herlev-Gentofte Hospital, University of Copenhagen, Denmark,
• Dr. Mark Boguniewicz, Professor of Allergy-Immunology, Department of Pediatrics, National Jewish Health and University of Colorado School of Medicine
• Dr. Phyllis C Zee, Professor, and Chief, Division of Sleep Medicine, Northwestern University, Feinberg School of Medicine
• Dr. Noreen Nicol, Associate Professor, University of Colorado, College of Nursing
• Dr. Jeanine A Baqai, Assistant Professor of Ophthalmology, Northwestern University, Feinberg School of Medicine 

Practitioners and trainees need this knowledge to properly manage atopic dermatitis and to keep up with the impressive progress that has been made in managing and treating atopic dermatitis within the past few years. As such, the educational needs and objectives of the program are to allow attendees to be able to:
• Diagnose and assess the severity of atopic dermatitis.
• Identify the heterogeneous clinical characteristics and different phenotypes of atopic dermatitis
• Recognize the high patient-burden of atopic dermatitis
• Use an improved understanding of pathophysiology, disease course, and treatments in therapeutic decision making for atopic dermatitis and related comorbidities
• Use evidence-based treatment approaches for atopic dermatitis 
• Coordinators/Administrators: Please note that each attendee must be registered to attend this meeting.  If you are registering for a group, change the quantity number on the registration page to complete the registration.